Stay updated with breaking news from Rum lane. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
We visited 7 holiday bars to see which one was cheeriest inquirer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.com Daily Mail and Mail on Sunday newspapers.
The Tri-Town Music Program is now accepting applications for after-school small music classes held at Searsmont Town Library, 37 Main St. South. The program is available to students in the
Rumble Inc. (NASDAQ:RUM – Get Free Report)’s stock price was down 6.6% during trading on Monday . The company traded as low as $4.65 and last traded at $4.80. Approximately 2,167,731 shares changed hands during trading, an increase of 67% from the average daily volume of 1,298,102 shares. The stock had previously closed at $5.14. […]
Rumble Inc. (NASDAQ:RUM – Get Free Report) hit a new 52-week low on Monday . The stock traded as low as $4.44 and last traded at $4.50, with a volume of 1477299 shares. The stock had previously closed at $4.69. Rumble Trading Down 4.1 % The firm has a market cap of $1.74 billion, a […]
For those of us who love our brand of firewater, nothing else would quite do. Eventually, after far too long, the iconic Old Monk bottle began to rub glass shoulders with other famous brands in trendy, knowledgeably stocked bars abroad. In the meantime, supplies of Old Monk would mysteriously dry up in the local liquor shops, while other much inferior wannabes tried to take its place. And then, your 'distribution people' would fight back and the precious supply would break through the competition blockade.
Bristol Myers Squibb has acquired Orum Therapeutics' experimental therapy to treat a type of blood cancer for a total value of up to $180 million, the privately held company said on Monday. The therapy, ORM-6151, which helps degrade a specific protein hard to treat previously, has received the U.S. Food and Drug Administration's (FDA) clearance for an early stage study. The deal includes an upfront payment of $100 million and milestone payments, Orum said, without disclosing further details.